Roivant to Stop Lung Disease Drug Development After Trial Failure ...Middle East

Medscape - News
Roivant will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial. Reuters Health Information

Read More Details
Finally We wish PressBee provided you with enough information of ( Roivant to Stop Lung Disease Drug Development After Trial Failure )

Also on site :